No in-house lobbyists. The figure is what 4 outside firms reported being paid by the company (LD-2, rounded to $10K). This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodRoche Diagnostics reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), through 4 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Health Issues8/8
- Medicare/Medicaid8/8
- Trade (domestic/foreign)2/8
Bills named in the filings 11 bills, this period
- H.R. 5269 RESULTS Act8 filings
- S. 1717 Ensuring Patient Access to Critical Breakthrough Products Act of 20256 filings
- H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act5 filings
- S. 1000 / H.R. 2377, 118th Saving Access to Laboratory Services Act2 filings
- S. 5349 / H.R. 1691, 118th Ensuring Patient Access to Critical Breakthrough Products Act of 20242 filings
6 more, 5 named in only one filing · Show all 11
- H.R. 10445, 118th Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 Broad bill2 filings
- H.R. 2369, 118th VALID Act of 20231 filing
- H.R. 3975, 118th IT Service Corps Act1 filing
- H.R. 8188 Tribal Roads Improvement Act1 filing
- H.R. 8188, 118th Stealthing Act of 20241 filing
- H.R. 7623, 118th Telehealth Modernization Act of 2024 Broad bill1 filing
From the filings
“H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.”
“Ensuring Patient Access to Critical Breakthrough Products Act; HR 5269: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CMS
- HHS
The House and Senate appear in every quarter; agencies in 3 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Roche Diagnostics, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 42 sitting members of Congress in 2025–26.
See every candidate and member Roche Diagnostics gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in